Haematology and blood transfusion最新文献_第7页

Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group. 成人急性髓性白血病缓解后治疗的比较:ECOG研究的初步分析。东部肿瘤合作集团。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_48

P A Cassileth, D P Harrington, J D Hines, M M Oken, J J Mazza, P McGlave, J M Bennett, E Lynch, M J O'Connell

引用次数: 3

Sequential decision strategy of the AML Cooperative Group studies. AML合作群体的顺序决策策略研究。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_52

A Heinecke, M C Sauerland, T Büchner

引用次数: 1

Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia. 米托蒽醌和依托泊苷治疗复发难治性急性非淋巴细胞白血病。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_61

J M Rowe, J J Mazza, J D Hines, P A Cassileth, M M Oken, J M Bennett, J Andersen

引用次数: 10

Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. 评估成人急性淋巴细胞白血病治疗方案的长期随访的重要性。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_75

B Clarkson, J Gaynor, C Little, E Berman, S Kempin, M Andreeff, S Gulati, I Cunningham, T Gee

{"title":"Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia.","authors":"B Clarkson, J Gaynor, C Little, E Berman, S Kempin, M Andreeff, S Gulati, I Cunningham, T Gee","doi":"10.1007/978-3-642-74643-7_75","DOIUrl":"https://doi.org/10.1007/978-3-642-74643-7_75","url":null,"abstract":"<p><p>During the past 20 years, we have treated 250 previously untreated adults (greater than age 15 years) with acute lymphoblastic leukemia (ALL) with five successive multidrug protocols: L2, L10, L10M, L17/17M, and L20. The L10 and L10M protocols had the highest percentage of long-term (greater than 5 years) remissions (52% and 40% respectively) compared with the L2 and more recent protocols (24%-32%); this is partly attributable to a greater prevalence of adverse risk factors among the latter protocols. The overall long-term survival of the first 199 patients with minimum 3 years follow-up is now 31%, with 35% of the 163 patients achieving complete remission (CR) remaining free of relapse for greater than 5 years. The disease-free survival of the 163 patients reaches a plateau of 33% after 6 years. The percentages of patients subsequently relapsing after remaining in continuous CR for 1.5, 3, and 5 years are 42%, 28%, and 6%, respectively; no relapses have yet occurred after 6 years in this series. Postrelapse survival improved progressively with longer duration of first remission. The results of treatment in second or later remission with either chemotherapy or bone marrow transplantation (BMT) were unsatisfactory and there were only a few long-term survivors. Recently we have attempted to select patients at highest risk of early relapse for BMT in first remission, but the number of eligible patients actually having BMTs has been low for a variety of reasons, including early death, failure to reach CR, early relapse, patient refusal, or medical contraindications.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":12936,"journal":{"name":"Haematology and blood transfusion","volume":"33 ","pages":"397-408"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13334715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 29

Marrow grafting for acute leukemia: results and future treatment strategies. 骨髓移植治疗急性白血病:结果和未来的治疗策略。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_114

R Storb, C D Buckner, R A Clift, F R Appelbaum, K C Doney, P Martin, C Anasetti, J Hansen, J E Sanders, F B Petersen

引用次数: 2

Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany. 同种异体骨髓移植治疗儿童白血病:德意志联邦共和国的结果和策略。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_116

D Niethammer, T Klingebiel, R Dopfer, G Ehninger, G Henze, W Schaefer, B Stollmann, W Ebell, M Link, H Riehm

引用次数: 5

Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988). 荷兰儿童白血病研究小组:研究ALL VI的早期结果(1984-1988)。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_85

A J Veerman, K Hählen, W A Kamps, E F Vanleeuwen, G A de Vaan, E R Vanwering, A Vanderdoes-Vandenberg, G Solbu, S Suciu

引用次数: 38

Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987. 儿童急性淋巴细胞白血病治疗的结果:1981-1987年的gdr经验。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_86

F Zintl, H Malke, M Reimann, W Dörffel, M Domula, G Eggers, P Exadaktylos, W Kotte, I Krause, W Kunert

引用次数: 3

Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations. 通过轮换非交叉耐药组合改善儿童急性淋巴细胞白血病高白细胞计数(大于100/nl)的预后。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_88

G E Janka-Schaub, U Goebel, U Graubner, R J Haas, H Juergens, H J Spaar, K Winkler

引用次数: 2

Hepatosplenic candidiasis in acute leukemias. 急性白血病的肝脾念珠菌病。

Haematology and blood transfusion Pub Date : 1990-01-01 DOI: 10.1007/978-3-642-74643-7_99

M von Eiff, M Essink, N Roos, H Schmidt, W Hiddemann, T Büchner, J van de Loo

引用次数: 2